1. Home
  2. DRMA vs TWAV Comparison

DRMA vs TWAV Comparison

Compare DRMA & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

N/A

Current Price

$0.58

Market Cap

5.6M

Sector

Health Care

ML Signal

N/A

Logo TaoWeave Inc. Common Stock

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.18

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DRMA
TWAV
Founded
2014
N/A
Country
United States
United States
Employees
N/A
130
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.1M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
DRMA
TWAV
Price
$0.58
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 95.3K
20.6K
Earning Date
11-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 90.77
EPS
N/A
★ N/A
Revenue
N/A
★ $2,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$650.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.48
52 Week Low
$0.57
$0.58
52 Week High
$4.66
$2.58

Technical Indicators

Market Signals
Indicator
DRMA
TWAV
Relative Strength Index (RSI) 30.10 35.34
Support Level N/A $1.14
Resistance Level $1.40 $1.50
Average True Range (ATR) 0.09 0.09
MACD -0.01 -0.01
Stochastic Oscillator 0.00 8.21

Price Performance

Historical Comparison
DRMA
TWAV

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.

Share on Social Networks: